Financhill
Back

Editas Medicine Vs. Regenxbio Industry Stock Comparison

Sell
22

EDIT
Editas Medicine

Last Price:
$1.33
Seasonality Move:
-11.28%
Sell
9

RGNX
Regenxbio

Last Price:
$7.65
Seasonality Move:
-8.12%
Sell
22
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $1.31. The Score for EDIT is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
9
Regenxbio (RGNX) is a Sell

Is Regenxbio a Buy, Sell or Hold?

  • The current Regenxbio [RGNX] share price is $7.63. The Score for RGNX is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
  • RGNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $1.31
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight selling pressure.

RGNX Stock Price Chart

What is Regenxbio's stock price today?

  • The Regenxbio share price today is $7.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGNX is experiencing buying pressure, which is a positive indicator for future bullish movement.

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.36 Sell
Relative Strength Index (14 RSI): 23.89 Sell
Chaikin Money Flow: -1676224 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.63 - 2.43) Sell
Bollinger Bands (100): (2.37 - 4.05) Sell

RGNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 36.19 Sell
Chaikin Money Flow: 5857711 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.41 - 9.97) Sell
Bollinger Bands (100): (9.16 - 12.08) Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.54 Sell
20-day SMA: 1.92 Sell
50-day SMA: 2.6 Sell
200-day SMA: 4.58 Sell
8-day EMA: 1.53 Sell
20-day EMA: 1.88 Sell
50-day EMA: 2.47 Sell
200-day EMA: 4.44 Sell

RGNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.27 Sell
20-day SMA: 9.07 Sell
50-day SMA: 9.56 Sell
200-day SMA: 13.31 Sell
8-day EMA: 8.2 Sell
20-day EMA: 8.85 Sell
50-day EMA: 9.58 Sell
200-day EMA: 12.46 Sell

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and an increase next year of $1.18 per share.

Regenxbio Earnings Growth & RGNX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $3.97 per share.

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regenxbio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):